Batefenterol/Fluticasone Furoate

N/A

Report date: 2025/11/14 13:58:51

Base Information

Drug NameBatefenterol/Fluticasone Furoate
Drug Alias NameFF/GSK-961081GSK-961081/FFFF/'081'081/FFFluticasone furoate/TD-5959 +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsYes Fluticasone FuroateBatefenterol Succinate
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline PlcInnoviva Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A